Mallinckrodt plc

2024 Q3 Form 10-Q Financial Statement

#000156789224000030 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $291.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $808.9M
Prepaid Expenses
Receivables $395.3M
Other Receivables
Total Short-Term Assets $1.652B
YoY Change -10.96%
LONG-TERM ASSETS
Property, Plant & Equipment $346.5M
YoY Change -23.54%
Goodwill
YoY Change
Intangibles $560.3M
YoY Change -78.29%
Long-Term Investments
YoY Change
Other Assets $230.3M
YoY Change 6.18%
Total Long-Term Assets $1.922B
YoY Change -40.89%
TOTAL ASSETS
Total Short-Term Assets $1.652B
Total Long-Term Assets $1.922B
Total Assets $3.574B
YoY Change -30.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $86.00M
YoY Change 3.12%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $6.500M
YoY Change -99.73%
Total Short-Term Liabilities $482.0M
YoY Change -85.19%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $91.60M
YoY Change 31.42%
Total Long-Term Liabilities $91.60M
YoY Change 31.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $482.0M
Total Long-Term Liabilities $91.60M
Total Liabilities $2.526B
YoY Change -43.65%
SHAREHOLDERS EQUITY
Retained Earnings -$146.9M
YoY Change -90.73%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.049B
YoY Change
Total Liabilities & Shareholders Equity $3.574B
YoY Change -30.02%

Cashflow Statement

Concept 2024 Q3 2024 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13200000 shares
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
899600000 usd
us-gaap Interest Income Other
InterestIncomeOther
9400000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15800000 usd
CY2024Q2 mnk Liabilities Management And Separation Costs
LiabilitiesManagementAndSeparationCosts
10300000 usd
CY2024Q2 us-gaap Reorganization Items
ReorganizationItems
0 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29500000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13900000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-43400000 usd
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
100000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.20
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-56.74
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.20
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-56.74
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19.7 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13200000 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.20
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-56.74
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.20
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-56.74
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5400000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6500000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19696335 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19696335 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19696335 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19696335 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19696335 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19696335 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 mnk Liabilities Management And Separation Costs
LiabilitiesManagementAndSeparationCosts
10300000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27400000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-56600000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
59400000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
162600000 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
6000000.0 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
4700000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3500000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1200000 usd
CY2023Q2 us-gaap Reorganization Items
ReorganizationItems
4000000.0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-219700000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
528100000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-747800000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19.7 shares
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
982100000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
623100000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
744900000 usd
us-gaap Gross Profit
GrossProfit
359000000.0 usd
us-gaap Gross Profit
GrossProfit
154700000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
264800000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
240400000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57100000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
560300000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
608400000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
784700000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
801000000.0 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230300000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
240700000 usd
CY2024Q2 us-gaap Assets
Assets
3574000000 usd
CY2023Q4 us-gaap Assets
Assets
3733600000 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6500000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6500000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
86000000.0 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
100400000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58900000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
82800000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
17100000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
20100000 usd
CY2024Q2 mnk Acthar Gel Related Settlement Current
ActharGelRelatedSettlementCurrent
21300000 usd
CY2023Q4 mnk Acthar Gel Related Settlement Current
ActharGelRelatedSettlementCurrent
21500000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
292200000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
269900000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
482000000.0 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
501200000 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1739800000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1755900000 usd
CY2024Q2 mnk Acthar Gel Related Settlement Non Current
ActharGelRelatedSettlementNonCurrent
117200000 usd
CY2024Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
39900000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
40600000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57300000 usd
us-gaap Restructuring Charges
RestructuringCharges
10400000 usd
us-gaap Restructuring Charges
RestructuringCharges
1000000.0 usd
mnk Liabilities Management And Separation Costs
LiabilitiesManagementAndSeparationCosts
17000000.0 usd
mnk Liabilities Management And Separation Costs
LiabilitiesManagementAndSeparationCosts
15200000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
9700000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-159200000 usd
us-gaap Interest Expense
InterestExpense
118500000 usd
us-gaap Interest Expense
InterestExpense
324600000 usd
us-gaap Interest Income Other
InterestIncomeOther
12800000 usd
us-gaap Reorganization Items
ReorganizationItems
0 usd
us-gaap Reorganization Items
ReorganizationItems
9600000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-499800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
497300000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-109000000.0 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-997100000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
300000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-5.53
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-75.68
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-75.68
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13200000 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-5.53
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-75.68
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-75.68
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13200000 shares
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3500000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3600000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
10100000 usd
CY2024Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-100000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46800000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-741400000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8300000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1800000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5800000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-200000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-117000000.0 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-993300000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
291100000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
262700000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5400000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6500000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
395300000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
377500000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
808900000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
982700000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
156900000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
138900000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
1652200000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1761800000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
346500000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
321700000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
608400000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
784700000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
801000000.0 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230300000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
240700000 usd
CY2024Q2 us-gaap Assets
Assets
3574000000 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6500000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6500000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
86000000.0 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
100400000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58900000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
82800000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
17100000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
20100000 usd
CY2024Q2 mnk Acthar Gel Related Settlement Current
ActharGelRelatedSettlementCurrent
21300000 usd
CY2023Q4 mnk Acthar Gel Related Settlement Current
ActharGelRelatedSettlementCurrent
21500000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
292200000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
482000000.0 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
501200000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1755900000 usd
CY2024Q2 mnk Acthar Gel Related Settlement Non Current
ActharGelRelatedSettlementNonCurrent
117200000 usd
CY2023Q4 mnk Acthar Gel Related Settlement Non Current
ActharGelRelatedSettlementNonCurrent
128500000 usd
CY2024Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
39900000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
40600000 usd
CY2024Q2 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
34600000 usd
CY2023Q4 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
35100000 usd
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
20400000 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
19600000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
91600000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
92500000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
2525500000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2573400000 usd
CY2024Q2 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
0 usd
CY2023Q4 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19696335 shares
CY2024Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
200000 usd
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
200000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1199900000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1194600000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4700000 usd
CY2024Q2 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
34600000 usd
CY2023Q4 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
35100000 usd
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
20400000 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
19600000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
91600000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
92500000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
2525500000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2573400000 usd
CY2023Q4 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
0 usd
CY2024Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
200000 usd
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
200000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1199900000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1194600000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4700000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3600000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146900000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38200000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1048500000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1160200000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3574000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3733600000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67200000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
286200000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
16300000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
475500000 usd
mnk Amortization Accretion Expense On Debt Premiumdiscount And Settlement Obligation
AmortizationAccretionExpenseOnDebtPremiumdiscountAndSettlementObligation
-2100000 usd
mnk Amortization Accretion Expense On Debt Premiumdiscount And Settlement Obligation
AmortizationAccretionExpenseOnDebtPremiumdiscountAndSettlementObligation
138600000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5800000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16800000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18600000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14400000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-161600000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-75700000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11500000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-24500000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-5900000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
159400000 usd
mnk Increase Decrease In Medicaid Lawsuit
IncreaseDecreaseInMedicaidLawsuit
-21400000 usd
mnk Increase Decrease In Medicaid Lawsuit
IncreaseDecreaseInMedicaidLawsuit
-16500000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
41000000.0 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
12800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47000000.0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
121000000.0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50900000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26300000 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
22600000 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-700000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-700000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27600000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
4400000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
22000000.0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-200000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3600000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146900000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1048500000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1160200000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3574000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3733600000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67200000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
286200000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
16300000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
475500000 usd
mnk Amortization Accretion Expense On Debt Premiumdiscount And Settlement Obligation
AmortizationAccretionExpenseOnDebtPremiumdiscountAndSettlementObligation
-2100000 usd
mnk Amortization Accretion Expense On Debt Premiumdiscount And Settlement Obligation
AmortizationAccretionExpenseOnDebtPremiumdiscountAndSettlementObligation
138600000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5800000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16800000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18600000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14400000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-161600000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-75700000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11500000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-24500000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-5900000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
159400000 usd
mnk Increase Decrease In Medicaid Lawsuit
IncreaseDecreaseInMedicaidLawsuit
-21400000 usd
mnk Increase Decrease In Medicaid Lawsuit
IncreaseDecreaseInMedicaidLawsuit
-16500000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
41000000.0 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
12800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47000000.0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50900000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26300000 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
22600000 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-700000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27600000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25600000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
4400000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
22000000.0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-200000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4600000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22100000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2200000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1100000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12600000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
72200000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
343400000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
466700000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356000000.0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
538900000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
291100000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
480600000 usd
CY2024Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
23600000 usd
CY2023Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
22700000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1100000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12600000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
343400000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
466700000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356000000.0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
538900000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
291100000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
480600000 usd
CY2024Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
23600000 usd
CY2023Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
22700000 usd
CY2024Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
41300000 usd
CY2023Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
35600000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356000000.0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
538900000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1160200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-65400000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4800000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1900000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1091900000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-43300000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3500000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3400000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1048500000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1613700000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2600000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1364400000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-747800000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6400000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
-100000 shares
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2500000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
625400000 usd
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportable_segment
mnk Cash Paid Reorganization Items
CashPaidReorganizationItems
19300000 usd
mnk Cash Paid Reorganization Items
CashPaidReorganizationItems
14600000 usd
CY2024Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
41300000 usd
CY2023Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
35600000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356000000.0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
538900000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1160200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-65400000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4800000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1900000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1091900000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-43300000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3500000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3400000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1048500000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1613700000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-249300000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2600000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2600000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1364400000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-747800000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6400000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
-100000 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
625400000 usd
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportable_segment
mnk Cash Paid Reorganization Items
CashPaidReorganizationItems
19300000 usd
mnk Cash Paid Reorganization Items
CashPaidReorganizationItems
14600000 usd
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its results based on a “52-53 week” year ending on the last Friday of December. Unless otherwise indicated, the three and six months ended June 28, 2024 (Successor) refers to the thirteen and twenty-six week periods ended June 28, 2024 (Successor) and the three and six months ended June 30, 2023 (Predecessor) refers to the thirteen and twenty-six week periods ended June 30, 2023 (Predecessor).</span></div>
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its results based on a “52-53 week” year ending on the last Friday of December. Unless otherwise indicated, the three and six months ended June 28, 2024 (Successor) refers to the thirteen and twenty-six week periods ended June 28, 2024 (Successor) and the three and six months ended June 30, 2023 (Predecessor) refers to the thirteen and twenty-six week periods ended June 30, 2023 (Predecessor).</span></div>
CY2022Q4 mnk Revenue Reserves
RevenueReserves
294000000.0 usd
mnk Revenue Reserve Provision
RevenueReserveProvision
752800000 usd
mnk Revenue Reserve Paymentsor Credits
RevenueReservePaymentsorCredits
-782300000 usd
CY2023Q2 mnk Revenue Reserves
RevenueReserves
264500000 usd
CY2023Q4 mnk Revenue Reserves
RevenueReserves
227400000 usd
mnk Revenue Reserve Provision
RevenueReserveProvision
869200000 usd
mnk Revenue Reserve Paymentsor Credits
RevenueReservePaymentsorCredits
-846800000 usd
CY2024Q2 mnk Revenue Reserves
RevenueReserves
249800000 usd
CY2024Q2 mnk Accrued Medicaid
AccruedMedicaid
35400000 usd
CY2023Q4 mnk Accrued Medicaid
AccruedMedicaid
59000000 usd
CY2024Q2 mnk Accrued Rebates
AccruedRebates
36800000 usd
CY2023Q4 mnk Accrued Rebates
AccruedRebates
35100000 usd
CY2022Q4 mnk Revenue Reserves
RevenueReserves
294000000.0 usd
mnk Revenue Reserve Provision
RevenueReserveProvision
752800000 usd
mnk Revenue Reserve Paymentsor Credits
RevenueReservePaymentsorCredits
-782300000 usd
CY2023Q2 mnk Revenue Reserves
RevenueReserves
264500000 usd
CY2023Q4 mnk Revenue Reserves
RevenueReserves
227400000 usd
mnk Revenue Reserve Provision
RevenueReserveProvision
869200000 usd
mnk Revenue Reserve Paymentsor Credits
RevenueReservePaymentsorCredits
-846800000 usd
CY2024Q2 mnk Revenue Reserves
RevenueReserves
249800000 usd
CY2024Q2 mnk Accrued Medicaid
AccruedMedicaid
35400000 usd
CY2023Q4 mnk Accrued Medicaid
AccruedMedicaid
59000000 usd
CY2024Q2 mnk Accrued Rebates
AccruedRebates
36800000 usd
CY2023Q4 mnk Accrued Rebates
AccruedRebates
35100000 usd
CY2024Q2 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
200000 usd
CY2023Q2 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
200000 usd
mnk Total Restructuring And Related Expense
TotalRestructuringAndRelatedExpense
10400000 usd
mnk Total Restructuring And Related Expense
TotalRestructuringAndRelatedExpense
1700000 usd
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
0 usd
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
700000 usd
us-gaap Restructuring Charges
RestructuringCharges
10400000 usd
us-gaap Restructuring Charges
RestructuringCharges
1000000.0 usd
CY2024Q2 mnk Restructuringand Related Costs Total Charges Expectedtobe Settledin Cash
RestructuringandRelatedCostsTotalChargesExpectedtobeSettledinCash
200000 usd
CY2023Q2 mnk Restructuringand Related Costs Total Charges Expectedtobe Settledin Cash
RestructuringandRelatedCostsTotalChargesExpectedtobeSettledinCash
-200000 usd
mnk Restructuring And Related Costs Non Cash Charges Including Accelerated Depreciation
RestructuringAndRelatedCostsNonCashChargesIncludingAcceleratedDepreciation
0 usd
mnk Restructuring And Related Costs Non Cash Charges Including Accelerated Depreciation
RestructuringAndRelatedCostsNonCashChargesIncludingAcceleratedDepreciation
-800000 usd
mnk Restructuringand Related Costs Total Charges Expectedtobe Settledin Cash
RestructuringandRelatedCostsTotalChargesExpectedtobeSettledinCash
10400000 usd
mnk Restructuringand Related Costs Total Charges Expectedtobe Settledin Cash
RestructuringandRelatedCostsTotalChargesExpectedtobeSettledinCash
900000 usd
CY2024Q2 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
200000 usd
CY2023Q2 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
200000 usd
mnk Total Restructuring And Related Expense
TotalRestructuringAndRelatedExpense
10400000 usd
mnk Total Restructuring And Related Expense
TotalRestructuringAndRelatedExpense
1700000 usd
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
0 usd
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
700000 usd
us-gaap Restructuring Charges
RestructuringCharges
10400000 usd
us-gaap Restructuring Charges
RestructuringCharges
1000000.0 usd
CY2024Q2 mnk Restructuringand Related Costs Total Charges Expectedtobe Settledin Cash
RestructuringandRelatedCostsTotalChargesExpectedtobeSettledinCash
200000 usd
CY2023Q2 mnk Restructuringand Related Costs Total Charges Expectedtobe Settledin Cash
RestructuringandRelatedCostsTotalChargesExpectedtobeSettledinCash
-200000 usd
mnk Restructuring And Related Costs Non Cash Charges Including Accelerated Depreciation
RestructuringAndRelatedCostsNonCashChargesIncludingAcceleratedDepreciation
0 usd
mnk Restructuringand Related Costs Total Charges Expectedtobe Settledin Cash
RestructuringandRelatedCostsTotalChargesExpectedtobeSettledinCash
10400000 usd
mnk Restructuringand Related Costs Total Charges Expectedtobe Settledin Cash
RestructuringandRelatedCostsTotalChargesExpectedtobeSettledinCash
900000 usd
mnk Schedule Of Restructuring Charges Incurred Cumulative To Date Tabletext Block
ScheduleOfRestructuringChargesIncurredCumulativeToDateTabletextBlock
et restructuring and related charges incurred for the 2021 and 2018 Programs were as follows as of June 28, 2024 (Successor):<div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:75.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.028%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021 Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2018 Program</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Specialty Brands</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Specialty Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">96.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">119.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13200000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29500000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95800000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.471
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.138
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
528100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
497300000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-219700000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-499800000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.404
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.995
us-gaap Income Taxes Paid
IncomeTaxesPaid
2700000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
137800000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
33100000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
33300000 usd
mnk Schedule Of Restructuring Charges Incurred Cumulative To Date Tabletext Block
ScheduleOfRestructuringChargesIncurredCumulativeToDateTabletextBlock
et restructuring and related charges incurred for the 2021 and 2018 Programs were as follows as of June 28, 2024 (Successor):<div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:75.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.028%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021 Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2018 Program</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Specialty Brands</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Specialty Generics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">96.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">119.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13200000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29500000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.471
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.138
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
528100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
497300000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-219700000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-499800000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.404
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.995
us-gaap Income Taxes Paid
IncomeTaxesPaid
2700000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
137800000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
33100000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
33300000 usd
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
1800000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
1700000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13200000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
1800000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
1700000 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19.7 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13200000 shares
CY2024Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
94300000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
98000000.0 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
431700000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
501800000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
282900000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
382900000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
808900000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
982700000 usd
CY2024Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
94300000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
98000000.0 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
431700000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
501800000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
382900000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
374800000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
331300000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28300000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9600000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
346500000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
321700000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
8700000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
11800000 usd
us-gaap Depreciation
Depreciation
19000000.0 usd
us-gaap Depreciation
Depreciation
23700000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
374800000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
331300000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28300000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9600000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
346500000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
321700000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
8700000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
11800000 usd
us-gaap Depreciation
Depreciation
19000000.0 usd
us-gaap Depreciation
Depreciation
23700000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23300000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
129300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
262500000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23300000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
129300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
262500000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
42300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
74800000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
68400000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
62000000.0 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
55600000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
46300000 usd
CY2024Q2 mnk Debt Instrument Face Amount Current Maturity
DebtInstrumentFaceAmountCurrentMaturity
6500000 usd
CY2024Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0 usd
CY2023Q4 mnk Debt Instrument Face Amount Current Maturity
DebtInstrumentFaceAmountCurrentMaturity
6500000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6500000 usd
CY2023Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0 usd
CY2024Q2 mnk Debt Instrument Face Amount Noncurrent Maturity
DebtInstrumentFaceAmountNoncurrentMaturity
1637000000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1742300000 usd
CY2024Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2500000 usd
CY2023Q4 mnk Debt Instrument Face Amount Noncurrent Maturity
DebtInstrumentFaceAmountNoncurrentMaturity
1641300000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1758800000 usd
CY2023Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2900000 usd
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1643500000 usd
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1643500000 usd
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1748800000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2500000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1647800000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1765300000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2900000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
42300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
74800000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
68400000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
62000000.0 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
55600000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
46300000 usd
CY2024Q2 mnk Debt Instrument Face Amount Current Maturity
DebtInstrumentFaceAmountCurrentMaturity
6500000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6500000 usd
CY2024Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0 usd
CY2023Q4 mnk Debt Instrument Face Amount Current Maturity
DebtInstrumentFaceAmountCurrentMaturity
6500000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6500000 usd
CY2023Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0 usd
CY2024Q2 mnk Debt Instrument Face Amount Noncurrent Maturity
DebtInstrumentFaceAmountNoncurrentMaturity
1637000000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1742300000 usd
CY2024Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2500000 usd
CY2023Q4 mnk Debt Instrument Face Amount Noncurrent Maturity
DebtInstrumentFaceAmountNoncurrentMaturity
1641300000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1758800000 usd
CY2023Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2900000 usd
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1643500000 usd
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1643500000 usd
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1748800000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2500000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1647800000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1765300000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2900000 usd
CY2024Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
35200000 usd
CY2024Q2 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
600000 usd
CY2024Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
32100000 usd
CY2024Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
14200000 usd
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
69400000 usd
CY2023Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
28900000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
12900000 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
22600000 usd
CY2024Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4300000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2700000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1200000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
16300000 usd
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
860000000 usd
CY2024Q2 mnk Derivative Interest Rate Cap Premium
DerivativeInterestRateCapPremium
20000000 usd
CY2023Q1 us-gaap Derivative Cap Interest Rate
DerivativeCapInterestRate
0.0384
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1748800000 usd
CY2024Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1794800000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1765300000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1731200000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportable_segment
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportable_segment
CY2024Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
-3400000 usd
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
-2700000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
200000 usd
CY2024Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
35200000 usd
CY2024Q2 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
600000 usd
CY2024Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
32100000 usd
CY2024Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
14200000 usd
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
69400000 usd
CY2023Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
28900000 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
12900000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
85100000 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
22600000 usd
CY2024Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4300000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2700000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1200000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
16300000 usd
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
860000000 usd
CY2024Q2 mnk Derivative Interest Rate Cap Premium
DerivativeInterestRateCapPremium
20000000 usd
CY2023Q1 us-gaap Derivative Cap Interest Rate
DerivativeCapInterestRate
0.0384
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1748800000 usd
CY2024Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1794800000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1765300000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1731200000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportable_segment
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportable_segment
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
514300000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
475000000.0 usd
CY2024Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
-3400000 usd
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
-2700000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
200000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
-200000 usd
CY2024Q2 mnk Bad Debt Expense Customer Bankruptcy Pre Petition Amount
BadDebtExpenseCustomerBankruptcyPrePetitionAmount
6400000 usd
CY2023Q2 mnk Bad Debt Expense Customer Bankruptcy Pre Petition Amount
BadDebtExpenseCustomerBankruptcyPrePetitionAmount
0 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27400000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-56600000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
59400000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
162600000 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
6000000.0 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
4700000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1200000 usd
CY2024Q2 us-gaap Reorganization Items
ReorganizationItems
0 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
-200000 usd
CY2024Q2 mnk Bad Debt Expense Customer Bankruptcy Pre Petition Amount
BadDebtExpenseCustomerBankruptcyPrePetitionAmount
6400000 usd
CY2023Q2 mnk Bad Debt Expense Customer Bankruptcy Pre Petition Amount
BadDebtExpenseCustomerBankruptcyPrePetitionAmount
0 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27400000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-56600000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
59400000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
162600000 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
6000000.0 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
4700000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3500000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1200000 usd
CY2024Q2 us-gaap Reorganization Items
ReorganizationItems
0 usd
CY2023Q2 us-gaap Reorganization Items
ReorganizationItems
4000000.0 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29500000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-219700000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
982100000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
899600000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
-5300000 usd
us-gaap Restructuring Charges
RestructuringCharges
10400000 usd
us-gaap Restructuring Charges
RestructuringCharges
1000000.0 usd
mnk Bad Debt Expense Customer Bankruptcy Pre Petition Amount
BadDebtExpenseCustomerBankruptcyPrePetitionAmount
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
9700000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-159200000 usd
us-gaap Interest Expense
InterestExpense
118500000 usd
us-gaap Interest Expense
InterestExpense
324600000 usd
us-gaap Interest Income Other
InterestIncomeOther
9400000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15800000 usd
us-gaap Reorganization Items
ReorganizationItems
9600000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-499800000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
514300000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
475000000.0 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
982100000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
899600000 usd
CY2023Q2 us-gaap Reorganization Items
ReorganizationItems
4000000.0 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29500000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-219700000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
982100000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
899600000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
-5300000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
-5300000 usd
us-gaap Restructuring Charges
RestructuringCharges
10400000 usd
us-gaap Restructuring Charges
RestructuringCharges
1000000.0 usd
mnk Bad Debt Expense Customer Bankruptcy Pre Petition Amount
BadDebtExpenseCustomerBankruptcyPrePetitionAmount
6400000 usd
mnk Bad Debt Expense Customer Bankruptcy Pre Petition Amount
BadDebtExpenseCustomerBankruptcyPrePetitionAmount
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
9700000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-159200000 usd
us-gaap Interest Expense
InterestExpense
118500000 usd
us-gaap Interest Expense
InterestExpense
324600000 usd
us-gaap Interest Income Other
InterestIncomeOther
12800000 usd
us-gaap Interest Income Other
InterestIncomeOther
9400000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15800000 usd
us-gaap Reorganization Items
ReorganizationItems
0 usd
us-gaap Reorganization Items
ReorganizationItems
9600000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-499800000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
514300000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
475000000.0 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
982100000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
899600000 usd

Files In Submission

Name View Source Status
0001567892-24-000030-index-headers.html Edgar Link pending
0001567892-24-000030-index.html Edgar Link pending
0001567892-24-000030.txt Edgar Link pending
0001567892-24-000030-xbrl.zip Edgar Link pending
exhibit101-mnk_rsuxec2024x.htm Edgar Link pending
exhibit102-mnk_rsuxceo2024.htm Edgar Link pending
exhibit103-mnk_rsuxdirecto.htm Edgar Link pending
exhibit104-mnk_psuxec2024x.htm Edgar Link pending
exhibit105-mnk_psuxceo2024.htm Edgar Link pending
exhibit106-mnk_psuxdirecto.htm Edgar Link pending
exhibit107-mnk_transaction.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mnk-20240628.htm Edgar Link pending
mnk-20240628.xsd Edgar Link pending
mnkex43supplementalindentu.htm Edgar Link pending
mnkexhibit311062824.htm Edgar Link pending
mnk-20240628_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
mnk-20240628_def.xml Edgar Link unprocessable
mnk-20240628_lab.xml Edgar Link unprocessable
mnk-20240628_pre.xml Edgar Link unprocessable
mnk-20240628_htm.xml Edgar Link completed
mnkexhibit312062824.htm Edgar Link pending
mnkexhibit321062824.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending